Neoadjuvant low-dose radiotherapy plus durvalumab and chemotherapy for potentially resectable stage III NSCLC: A phase Ib dose-escalation study
Article in Radiotherapy and Oncology (April 2024)
The most recent citing publications are shown below. View all 114 publications that cite this research output on Dimensions.
Article in Radiotherapy and Oncology (April 2024)
Article in Medicine (April 2024)
Article in Cancers (March 2024)